GB9212737D0 - Veterinary product - Google Patents

Veterinary product

Info

Publication number
GB9212737D0
GB9212737D0 GB929212737A GB9212737A GB9212737D0 GB 9212737 D0 GB9212737 D0 GB 9212737D0 GB 929212737 A GB929212737 A GB 929212737A GB 9212737 A GB9212737 A GB 9212737A GB 9212737 D0 GB9212737 D0 GB 9212737D0
Authority
GB
United Kingdom
Prior art keywords
mmol
excess
precursors
bicarbonate
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929212737A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Laboratories Ltd
Original Assignee
Norbrook Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Ltd filed Critical Norbrook Laboratories Ltd
Priority to GB929212737A priority Critical patent/GB9212737D0/en
Publication of GB9212737D0 publication Critical patent/GB9212737D0/en
Priority to AT93913325T priority patent/ATE157878T1/en
Priority to NZ253254A priority patent/NZ253254A/en
Priority to PCT/GB1993/001220 priority patent/WO1993025214A1/en
Priority to CA002137469A priority patent/CA2137469A1/en
Priority to AU43438/93A priority patent/AU669909B2/en
Priority to JP6501264A priority patent/JPH07507788A/en
Priority to DK93913325.2T priority patent/DK0644767T3/en
Priority to EP93913325A priority patent/EP0644767B3/en
Priority to ES93913325T priority patent/ES2108279T3/en
Priority to DE69313850T priority patent/DE69313850T2/en
Priority to GR970403128T priority patent/GR3025479T3/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A composition for the treatment of livestock suffering from disorders such as fluid depletion, acidosis, and imbalances or loss of essential electrolytes, same to be made up in water at point of use as an oral rehydration formulation, comprises an intimate mixture of an energy source, electrolytes, and bicarbonate precursors, which precursors are provided as physiologically acceptable carboxylic acid anions with corresponding physiologically acceptable cations including sodium, the yield of bicarbonate being in excess of 30 millimole/litre (mmol/1) of final formulation, and the concentration of sodium being in excess of 80 mmol/1 of final formulation.
GB929212737A 1992-06-16 1992-06-16 Veterinary product Pending GB9212737D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB929212737A GB9212737D0 (en) 1992-06-16 1992-06-16 Veterinary product
DE69313850T DE69313850T2 (en) 1992-06-16 1993-06-09 VETERINAER PRODUCT FOR REHYDRATION
CA002137469A CA2137469A1 (en) 1992-06-16 1993-06-09 Veterinary rehydration product
NZ253254A NZ253254A (en) 1992-06-16 1993-06-09 Rehydration composition for animals comprising na and k electrolytes, (glucose) energy source, carboxylic acid bicarbonate precursors and optionally an orthophosphate
PCT/GB1993/001220 WO1993025214A1 (en) 1992-06-16 1993-06-09 Veterinary rehydration product
AT93913325T ATE157878T1 (en) 1992-06-16 1993-06-09 VETERINARY PRODUCT FOR REHYDRATION
AU43438/93A AU669909B2 (en) 1992-06-16 1993-06-09 Veterinary rehydration product
JP6501264A JPH07507788A (en) 1992-06-16 1993-06-09 veterinary rehydration products
DK93913325.2T DK0644767T3 (en) 1992-06-16 1993-06-09 Veterinary product for rehydration
EP93913325A EP0644767B3 (en) 1992-06-16 1993-06-09 Veterinary rehydration product
ES93913325T ES2108279T3 (en) 1992-06-16 1993-06-09 VETERINARY REHYDRATION PRODUCT.
GR970403128T GR3025479T3 (en) 1992-06-16 1997-11-26 Veterinary rehydration product.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929212737A GB9212737D0 (en) 1992-06-16 1992-06-16 Veterinary product

Publications (1)

Publication Number Publication Date
GB9212737D0 true GB9212737D0 (en) 1992-07-29

Family

ID=10717166

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929212737A Pending GB9212737D0 (en) 1992-06-16 1992-06-16 Veterinary product

Country Status (12)

Country Link
EP (1) EP0644767B3 (en)
JP (1) JPH07507788A (en)
AT (1) ATE157878T1 (en)
AU (1) AU669909B2 (en)
CA (1) CA2137469A1 (en)
DE (1) DE69313850T2 (en)
DK (1) DK0644767T3 (en)
ES (1) ES2108279T3 (en)
GB (1) GB9212737D0 (en)
GR (1) GR3025479T3 (en)
NZ (1) NZ253254A (en)
WO (1) WO1993025214A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2329336B (en) * 1996-05-14 1999-11-10 Norbrook Lab Ltd Oral rehydration product comprising glutamine
GB9609993D0 (en) * 1996-05-14 1996-07-17 Norbrook Lab Ltd Oral rehydration product
JP6822734B2 (en) 2014-11-19 2021-01-27 カルマーナ・リミテッド Oral rehydration composition and its method
EP4003052A1 (en) * 2019-07-29 2022-06-01 Nutreco IP Assets B.V. Electrolyte composition and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175701C (en) * 1982-08-25 1984-12-17 Aesculaap Bv PREPARATION FOR THE PREPARATION OF AN ORAL ADMINISTRATIVE ANIMAL SOLUTION.
AU571011B2 (en) * 1983-10-07 1988-03-31 State Of Victoria, The Treatment of neonatal calf diarrhoea
PT84833B (en) * 1986-05-09 1990-02-08 Beecham Group Plc Process for the preparation of a VETERINARY COMPOSITION CONTAINING IAO SODIUM
US5096894A (en) * 1990-04-03 1992-03-17 Bristol-Myers Squibb Company Rice dextrin oral rehydration solution

Also Published As

Publication number Publication date
NZ253254A (en) 1996-01-26
ATE157878T1 (en) 1997-09-15
DE69313850D1 (en) 1997-10-16
DE69313850T2 (en) 1998-01-22
EP0644767B1 (en) 1997-09-10
EP0644767A1 (en) 1995-03-29
ES2108279T3 (en) 1997-12-16
WO1993025214A1 (en) 1993-12-23
AU4343893A (en) 1994-01-04
EP0644767B3 (en) 2009-04-08
AU669909B2 (en) 1996-06-27
DK0644767T3 (en) 1997-10-13
GR3025479T3 (en) 1998-02-27
CA2137469A1 (en) 1993-12-23
JPH07507788A (en) 1995-08-31

Similar Documents

Publication Publication Date Title
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
ZA857270B (en) Tetralin derivatives,their preparation and their use
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
ES2135769T3 (en) DERIVATIVES OF ISOTIOUREA AS INHIBITORS OF NO-SINTASA.
JO1406B1 (en) Chemical compounds
GB8506027D0 (en) Pharmaceutical & dietary compositions
GB9212737D0 (en) Veterinary product
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
ES8304975A1 (en) Tryptamine derivatives of thienyloxypropanol amines, process for their preparation, pharmaceutical compositions containing them and preparation of the latter.
GR76886B (en)
ZA874470B (en) New tetrahydrobenzothiazoles,and the preparation and use thereof
EP0194579A3 (en) 3-pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
DE3360058D1 (en) Optically active derivatives of phenoxy-benzoic acid, process for their preparation and their use as herbicides
ES8305734A1 (en) 5(6)-Phenyl-sulfonyloxy-benzimidazole derivatives, process for their production, pharmaceutical compositions containing them and their use against liver disorders.
HUT38607A (en) Process for producing phenyl-ethyl-amino-propiophenone derivatives and pharmaceutical composition containing them as active agents
JPS55133317A (en) Preparation of healthy drinking water
ZA843615B (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states
EP0061917A3 (en) Collagen fibers for use in medical treatment
JPS56130297A (en) Treatment of sludge
JPS5651979A (en) Preparation of agar medium
MD512C2 (en) Inhibitor for vine grafts eyes development
ES8306729A1 (en) Novel 2-isopropyl-pyrido[2,1-b]quinazolines and their non-toxic salts, process for their preparation and pharmaceutical compositions containing these compounds